Proof Reports in MedComms: What Pharma Clients Are Now Demanding

Posted in Proof & MeasurementTagged Medcomms Agencies, Pharma, Proof Reports

There is a moment in every MedComms agency’s client review when the brief stops being about content and starts being about evidence. Pharma medical affairs teams are no longer satisfied with attendance figures and completion rates. They are asking a harder question: What changed?

The answer to that question lives in a proof report, and how your agency responds is increasingly shaping whether you renew mandates, win competitive tenders, and retain client relationships worth renewing.

What Is a Proof Report in Medical Education?

A proof report is a structured document, or data dashboard, that demonstrates measurable outcomes from an HCP education programme. It answers three questions:

The best proof reports connect education delivery directly to behaviour change data. The weakest proof reports present completion statistics and call it evidence.

Pharma clients, particularly in medical affairs and MSL functions, increasingly know the difference.

Why the Bar Has Raised

Three forces have converged to make proof reports a standard expectation rather than a differentiator:

Medical affairs accountability. Budgets allocated to HCP education programmes are scrutinised more rigorously than ever. Medical affairs directors are being asked to justify spend with evidence that meets the same standards expected of clinical research investments. Attendance registers do not pass that test.

Regulatory scrutiny of CME. Across Europe and increasingly in the US, there is growing regulatory interest in whether certified medical education programmes produce demonstrable behaviour change, not just knowledge transfer. Agencies that collect and report outcome data are ahead of this curve.

Completion rate fatigue. Pharma medical affairs teams have experienced programmes with 90%+ completion rates that produced no measurable change in prescribing behaviour or clinical practice. The industry has adjusted. “They completed it” is no longer an acceptable endpoint.

The Data Behind a Strong Proof Report

The most compelling proof reports are built from multiple data layers collected throughout the programme:

Pre-assessment data: baseline knowledge and confidence scores captured before any content is consumed. This is the starting line. Without it, you cannot claim movement.

Post-assessment data: the same measures captured at programme end, enabling direct comparison with baseline. The gap between pre and post is the distance travelled.

Longitudinal follow-up: the gold standard. Moore’s Level 5 (Performance) requires evidence that HCPs applied what they learned in practice. Six-week follow-up surveys that ask “how has your practice changed?” move proof reports from self-reported learning to behaviour change evidence.

Engagement depth data: which content modules were completed, how long was spent with each, which questions triggered most engagement, where HCPs dropped off. This contextualises outcome data and helps identify which programme elements drove the most change.

Cohort-level analysis: aggregate data across the HCP population, enabling statements like: “73% of participants moved from low-confidence to high-confidence on the primary clinical decision point.” Individual data is compliance-sensitive. Cohort data is the reportable asset.

How Distance Travelled Fits In

Distance travelled is the headline metric in a proof report: the single number that summarises programme impact in a form that makes sense to a medical affairs director in a budget review.

A distance travelled score of 38 percentage points means the programme moved HCPs 38% closer to the target clinical behaviour on average. That number travels well. It appears in executive summaries. It goes into tender responses. It is included in programme renewal discussions.

For MedComms agencies, the ability to produce a distance travelled score changes the commercial conversation. You stop presenting programme deliverables and start presenting programme outcomes. The difference matters at every stage of the client relationship.

Yoke Health’s platform automatically calculates distance travelled from pre- and post-assessment data, outputting client-ready proof reports that include cohort-level behaviour change evidence, longitudinal follow-up results, and engagement depth analytics.

What Proof Reports Are Not

A proof report is not:

These outputs have value in their context. They do not constitute proof of behaviour change. Pharma medical affairs teams who have been reviewing education programmes for several years are fluent in the difference.

Building Proof Report Capability Into Your Agency

The agencies that produce the strongest proof reports have made a structural decision: they instrument their education programmes to collect outcome data by design, not as an afterthought.

This means:

The infrastructure required to do this at scale is available. Platforms built for MedComms, including Yoke Health’s HIVE and iCases products, collect pre/post assessment data, run Moore’s Level 5 follow-up sequences automatically, and generate proof reports from live programme data.

For MedComms agencies operating at scale, manual data collection is no longer competitive. The agencies winning new mandates are the ones that can say: “Our platform generates your proof report automatically.”

The Commercial Case for Proof Reports

Proof reports are not a compliance cost. They are a commercial asset.

Mandate renewal. A proof report that shows 41 percentage points of average distance travelled across 500 HCPs is a strong argument for programme renewal. It is also a strong argument for programme expansion.

Competitive tender. When two MedComms agencies are pitching for the same mandate, the one with outcome data from comparable programmes has a differentiated proposal. “We can prove it works” beats “we think it will work.”

Client retention. Medical affairs clients who see consistent, credible outcome data from your programmes become structurally dependent on your capability. They are harder to lose to a competitor who cannot produce equivalent evidence.

White-label positioning. For agencies building branded platforms for pharma clients, the ability to generate proof reports under the client’s brand, without Yoke Health’s branding visible, means the agency owns the client relationship and the data. Yoke Health becomes the measurement infrastructure, invisible to the end client.

Getting Started

If your agency currently lacks proof report capability, the practical starting point is:

The agencies that have built this into their standard delivery model are not treating proof reports as an extra. They are treating them as the product.

Yoke Health helps MedComms agencies build proof report capability into their standard programme delivery. See how the platform works or get in touch to discuss a pilot.

Industry Context & Sources

The following sources informed the evidence standards discussed in this article:

• Pharma AI Training Programs: Curriculum Design & ROI, IntuitionLabs (2025). Covers Kirkpatrick’s four-level evaluation framework with specific HCP education metrics including pre/post assessment, behaviour application tracking, and ROI calculation for pharma training programmes.
• Digital Preceptorships: Medical Affairs Takes Training Beyond the Hospital, M-Phar. Discusses competency-based assessment approaches used by Medical Affairs teams, including engagement tracking and combined quantitative/qualitative measurement for HCP education outcomes.
• Pharma & Medtech Solutions for Effective Programs, Meplis. Industry platform addressing measurement of participation, engagement, and outcomes across pharmaceutical and medtech HCP education programmes.

Related Reading

• Distance Travelled in Medical Education: What MedComms Agencies Need to Know in 2025
• HCP Education in Biotech: Why Measuring Behaviour Change Is the Only Metric That Matters
• We didn’t deploy AI to do our jobs. We built it into how we work.